Cited by 178Inflammatory Bowel DiseaseNF-κB Signaling PathwaysProtein Kinase Regulation and GTPase Signaling

Mitogen activated protein kinases: a role in inflammatory bowel disease?

Open access
Broom, O J, Widjaya, B, Troelsen, J, Olsen, J, Nielsen, O H·2009·Clinical and Experimental Immunology

Abstract

Since their discovery more than 15 years ago, the mitogen activated protein kinases (MAPK) have been implicated in an ever-increasingly diverse array of pathways, including inflammatory signalling cascades. Inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, are characterized by the perpetual production of inflammatory mediators. Research into the transduction pathway behind this over-production has highlighted the potential mediating role for the MAPKs and their related signalling components. This review highlights some of the research into the role for the MAPKs and their related signalling proteins in influencing the progression of IBD.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2249.2009.04033.x

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

2 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Broom, O. J., Widjaya, B., Troelsen, J., Olsen, J., & Nielsen, O. H.
Affiliations
  • University of Copenhagen (DK)
  • Herlev Hospital (DK)
Corresponding author
  • Broom, O J
  • Nielsen, O H
Venue
Clinical and Experimental Immunology
Published
2009-09-30
Volume
158
Issue
3
Pages
272-280
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W2068392219
Cited by
177
References
77
Citations by year
2026: 8 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 17 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 13 · 2014: 6 · 2013: 8 · 2012: 8
FWCI
0.47
Type
journal article
Language
en
Open access
Locations
  • Clinical & Experimental Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
Aase og Ejnar Danielsens Fond
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
mitogen-activated protein kinase, inflammatory bowel disease, ulcerative colitis, Crohn's disease, inflammatory signalling, MAPK signaling, disease progression
MeSH terms
Humans, Inflammatory Bowel Diseases, Inflammation Mediators, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Protein Kinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review